Management of alcohol withdrawal delirium. An evidence-based practice guideline

Archives of Internal Medicine
M F Mayo-SmithWorking Group on the Management of Alcohol Withdrawal Delirium, Practice Guidelines Committee, American Society of Addiction

Abstract

Alcohol withdrawal delirium is the most serious manifestation of alcohol withdrawal. Evidence suggests that appropriate care improves mortality, but systematic reviews are unavailable. Articles with original data on management of alcohol withdrawal delirium underwent structured review and meta-analysis. Meta-analysis of 9 prospective controlled trials demonstrated that sedative-hypnotic agents are more effective than neuroleptic agents in reducing duration of delirium and mortality, with a relative risk of death when using neuroleptic agents of 6.6. Statistically significant differences among various benzodiazepines and barbiturates were not found. No deaths were reported in 217 patients from trials using benzodiazepines or barbiturates. Control of agitation should be achieved using parenteral rapid-acting sedative-hypnotic agents that are cross-tolerant with alcohol. Adequate doses should be used to maintain light somnolence for the duration of delirium. Coupled with comprehensive supportive medical care, this approach is highly effective in preventing morbidity and mortality.

Citations

Dec 18, 2013·Journal of Addiction Medicine·Elie Isenberg-GrzedaStephen E Nicolson
Nov 26, 2013·Archives of Women's Mental Health·Priya GopalanPierre N Azzam
Aug 24, 2013·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism
Jun 29, 2013·American Journal of Respiratory and Critical Care Medicine·Ashish J MehtaDavid M Guidot
May 2, 2014·CNS Drugs·Elizabeth C Perry
Jul 12, 2014·Industrial Psychiatry Journal·Shivanand Kattimani, Balaji Bharadwaj
Aug 19, 2006·European Archives of Psychiatry and Clinical Neuroscience·Michael SoykaGreif Sander
Jul 21, 2014·Disease-a-month : DM·Gourang Patel
May 22, 2008·Critical Care : the Official Journal of the Critical Care Forum·Marjolein de WitScott K Epstein
Feb 4, 2012·Journal of General Internal Medicine·Malaz A BoustaniChristopher M Callahan
May 25, 2012·Annals of Intensive Care·Samuel G RaynerUNKNOWN Study Institution
Dec 4, 2013·Annals of General Psychiatry·Dragana Ignjatovic-RisticSrdjan Stefanovic
Mar 19, 2009·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Ulf BerggrenJan Balldin
Jan 16, 2010·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·R MonteS Pértega
Feb 23, 2011·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Florian EyerThomas Zilker
Mar 19, 2011·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Bjarne ElholmUlrik Becker
Jun 12, 2012·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Yi-Lang TangLorenzo Leggio
Jul 14, 2012·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·G BrousseJ Schmidt
Jun 7, 2013·Addiction Science & Clinical Practice·Regina Makdissi, Scott H Stewart
Aug 31, 2010·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Shaun BlackRobert Gilbert
Aug 25, 2007·Current Treatment Options in Neurology·Jonathan I Ritvo, Charles Park
Oct 2, 2007·Nursing·Mary Lussier-CushingRobin Lipkis-Orlando
Jun 22, 2010·Expert Opinion on Emerging Drugs·Michael Soyka, Susanne Rösner
Sep 5, 2015·The American Journal of Drug and Alcohol Abuse·Adrian WongSandra L Kane-Gill
Feb 15, 2008·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Michael SoykaUNKNOWN WFSBP Task Force on Treatment Guidelines for Substance Use Disorders
Oct 7, 2005·Pharmacotherapy·Karen M StanleyUNKNOWN Department of Therapeutic Services, Medical University of South Carolina
Jun 30, 2009·Pharmacotherapy·Christopher E HaynerPamela J Bolton
May 12, 2010·Journal of Clinical Pharmacy and Therapeutics·R Barrons, N Roberts
Feb 11, 2015·Drugs·Antonio MirijelloGiovanni Addolorato
Nov 27, 2014·The New England Journal of Medicine·Marc A Schuckit
Sep 17, 2011·La Revue de médecine interne·N ThiercelinA Plat
Aug 4, 2016·Neurotoxicity Research·Patrycja KleczkowskaMagdalena Bujalska-Zadrozny
Aug 17, 2010·Emergency Medicine Clinics of North America·Jin H HanE Wesley Ely
Mar 22, 2013·The New England Journal of Medicine·Shamim H Nejad, Ednan K Bajwa
Dec 23, 2016·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Michael SoykaUNKNOWN WFSBP Task Force on Treatment Guidelines for Substance Use Disorders
Oct 6, 2011·Chest·Daniel E BrooksSteven C Curry
Jun 18, 2017·The Annals of Pharmacotherapy·Bethany R ShouldersSandra L Kane-Gill

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here